These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


308 related items for PubMed ID: 16189620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I, Rabinovitz M, Rosenfeld JB.
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [Abstract] [Full Text] [Related]

  • 3. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
    Ng TM, Konopka E, Hyderi AF, Hshieh S, Tsuji Y, Kim BJ, Han SY, Phan DH, Jeng AI, Lou M, Elkayam U.
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300
    [Abstract] [Full Text] [Related]

  • 4. Combination diuretic treatment in severe heart failure: a randomised controlled trial.
    Channer KS, McLean KA, Lawson-Matthew P, Richardson M.
    Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE, Jiang A, Devabhakthuni S, Ivaturi V, Liu T, Reed BN.
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [Abstract] [Full Text] [Related]

  • 6. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA, Ter Maaten JM, Houser SR, Vedage NA, Rao V, Ahmad T, Wilson FP, Testani JM.
    J Am Heart Assoc; 2018 Sep 18; 7(18):e009149. PubMed ID: 30371181
    [Abstract] [Full Text] [Related]

  • 7. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
    Moranville MP, Choi S, Hogg J, Anderson AS, Rich JD.
    Cardiovasc Ther; 2015 Apr 18; 33(2):42-9. PubMed ID: 25712736
    [Abstract] [Full Text] [Related]

  • 8. [Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
    Kirancumar, Loureiro PA, Correia JM.
    Rev Port Cardiol; 1989 Nov 18; 8(11):775-8. PubMed ID: 2631826
    [Abstract] [Full Text] [Related]

  • 9. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
    Steuber TD, Janzen KM, Howard ML.
    Pharmacotherapy; 2020 Sep 18; 40(9):924-935. PubMed ID: 32639593
    [Abstract] [Full Text] [Related]

  • 10. [Furosemide and metolazone: a highly effective diuretic combination].
    Furrer J, Hess OM, Kuhlmann U, Satz N, Siegenthaler W.
    Schweiz Med Wochenschr; 1980 Nov 29; 110(48):1825-9. PubMed ID: 7280609
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M, Altshuler J, Testani JM.
    Pharmacotherapy; 2016 Aug 29; 36(8):843-51. PubMed ID: 27321568
    [Abstract] [Full Text] [Related]

  • 12. Metolazone and its role in edema management.
    Sica DA.
    Congest Heart Fail; 2003 Aug 29; 9(2):100-5. PubMed ID: 12671341
    [Abstract] [Full Text] [Related]

  • 13. Metolazone in treatment of severe refractory congestive cardiac failure.
    Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ.
    Lancet; 1990 Jan 06; 335(8680):29-31. PubMed ID: 1967337
    [Abstract] [Full Text] [Related]

  • 14. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR, Kane RE.
    J Clin Pharmacol; 1977 Apr 06; 17(4):243-51. PubMed ID: 849998
    [Abstract] [Full Text] [Related]

  • 15. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
    Salahudin M, Shah H, Jan MU, Altaf A.
    J Pak Med Assoc; 2019 Dec 06; 69(12):1794-1799. PubMed ID: 31853105
    [Abstract] [Full Text] [Related]

  • 16. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
    Cox ZL, Hung R, Lenihan DJ, Testani JM.
    JACC Heart Fail; 2020 Mar 06; 8(3):157-168. PubMed ID: 31838029
    [Abstract] [Full Text] [Related]

  • 17. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC, Morales-Rull JL, Casado J, Freitas Ramírez A, Manzano L, Formiga F, CLOROTIC investigators.
    J Card Fail; 2016 Jul 06; 22(7):529-36. PubMed ID: 26576715
    [Abstract] [Full Text] [Related]

  • 18. [Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide].
    Groth H, Vetter H, Achermann R, Kuhlmann U, Siegenthaler W, Vetter W.
    Schweiz Med Wochenschr; 1985 Jan 12; 115(2):41-5. PubMed ID: 3969541
    [Abstract] [Full Text] [Related]

  • 19. Severe electrolyte disturbances associated with metolazone and furosemide.
    Black WD, Shiner PT, Roman J.
    South Med J; 1978 Apr 12; 71(4):380-1, 385. PubMed ID: 635611
    [Abstract] [Full Text] [Related]

  • 20. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec 12; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.